Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis

Inclusion Criteria: * Signed consent; * Participants aged 18 years or more; * Participants diagnosed with eosinophilic esophagitis, defined as: 1. Presence of symptoms of esophageal dysfunction intermittently or continuously during previous week to the screening visit; 2. Eosinophilic esophageal inflammation with ≥ 15 eosinophils/high-power field, in the screening endoscopy; 3. Exclusion of other causes of esophageal eosinophilia. Exclusion Criteria: * Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants; * Participants with a stricture on endoscopy that prevents passage of the endoscope; * History of alcohol abuse or drug use; * Use of concomitant therapies for any reason that may affect the assessment; * History of gastroesophageal surgery; * History of the abnormal gastrointestinal disorder; * Another disorder that causes esophageal eosinophilia; * Pregnancy or risk of pregnancy and lactating patients; * Participants with known allergy, contraindication or hypersensitivity to the components of the medicine used in the clinical trial; * Participation in clinical trial in the year prior to this study.